Safety of Clopidogrel vs. Ticagrelor in Dual Antiplatelet Therapy Regimens for High-Bleeding Risk Acute Coronary Syndrome Patients: A Comprehensive Meta-analysis of Adverse Outcomes

go back to reference Cardiovascular diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 18 Aug 2023. Cardiovascular diseases (CVDs). https://​www.​who.​int/​news-room/​fact-sheets/​detail/​cardiovascular-diseases-(cvds). Accessed 18 Aug 2023.

go back to reference Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet J-P, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Group ESD, Wijns W, Glineur D, Aboyans V, Achenbach S, Agewall S, Andreotti F, Barbato E, Baumbach A, Brophy J, Bueno H, Calvert PA, Capodanno D, Davierwala PM, Delgado V, Dudek D, Freemantle N, Funck-Brentano C, Gaemperli O, Gielen S, Gilard M, Gorenek B, Haasenritter J, Haude M, Ibanez B, Iung B, Jeppsson A, Katritsis D, Knuuti J, Kolh P, Leite-Moreira A, Lund LH, Maisano F, Mehilli J, Metzler B, Montalescot G, Pagano D, Petronio AS, Piepoli MF, Popescu BA, Sádaba R, Shlyakhto E, Silber S, Simpson IA, Sparv D, Tavilla G, Thiele H, Tousek P, Van Belle E, Vranckx P, Witkowski A, Zamorano JL, Roffi M, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet J-P, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, McDonagh TA, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Sousa-Uva M, Simpson IA, Zamorano JL, Pagano D, Freemantle N, Sousa-Uva M, Chettibi M, Sisakian H, Metzler B, İbrahimov F, Stelmashok VI, Postadzhiyan A, Skoric B, Eftychiou C, Kala P, Terkelsen CJ, Magdy A, Eha J, Niemelä M, Kedev S, Motreff P, Aladashvili A, Mehilli J, Kanakakis I-G, Becker D, Gudnason T, Peace A, Romeo F, Bajraktari G, Kerimkulova A, Rudzītis A, Ghazzal Z, Kibarskis A, Pereira B, Xuereb RG, Hofma SH, Steigen TK, Witkowski A, de Oliveira EI, Mot S, Duplyakov D, Zavatta M, Beleslin B, Kovar F, Bunc M, Ojeda S, Witt N, Jeger R, Addad F, Akdemir R, Parkhomenko A, Henderson R. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165. https://doi.org/10.1093/EURHEARTJ/EHY394.CrossRefPubMed Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet J-P, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Group ESD, Wijns W, Glineur D, Aboyans V, Achenbach S, Agewall S, Andreotti F, Barbato E, Baumbach A, Brophy J, Bueno H, Calvert PA, Capodanno D, Davierwala PM, Delgado V, Dudek D, Freemantle N, Funck-Brentano C, Gaemperli O, Gielen S, Gilard M, Gorenek B, Haasenritter J, Haude M, Ibanez B, Iung B, Jeppsson A, Katritsis D, Knuuti J, Kolh P, Leite-Moreira A, Lund LH, Maisano F, Mehilli J, Metzler B, Montalescot G, Pagano D, Petronio AS, Piepoli MF, Popescu BA, Sádaba R, Shlyakhto E, Silber S, Simpson IA, Sparv D, Tavilla G, Thiele H, Tousek P, Van Belle E, Vranckx P, Witkowski A, Zamorano JL, Roffi M, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet J-P, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, McDonagh TA, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Sousa-Uva M, Simpson IA, Zamorano JL, Pagano D, Freemantle N, Sousa-Uva M, Chettibi M, Sisakian H, Metzler B, İbrahimov F, Stelmashok VI, Postadzhiyan A, Skoric B, Eftychiou C, Kala P, Terkelsen CJ, Magdy A, Eha J, Niemelä M, Kedev S, Motreff P, Aladashvili A, Mehilli J, Kanakakis I-G, Becker D, Gudnason T, Peace A, Romeo F, Bajraktari G, Kerimkulova A, Rudzītis A, Ghazzal Z, Kibarskis A, Pereira B, Xuereb RG, Hofma SH, Steigen TK, Witkowski A, de Oliveira EI, Mot S, Duplyakov D, Zavatta M, Beleslin B, Kovar F, Bunc M, Ojeda S, Witt N, Jeger R, Addad F, Akdemir R, Parkhomenko A, Henderson R. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165. https://​doi.​org/​10.​1093/​EURHEARTJ/​EHY394.CrossRefPubMed

go back to reference Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57. https://doi.org/10.1056/NEJMOA0904327/SUPPL_FILE/NEJM_WALLENTIN_1045SA1.PDF.CrossRefPubMed Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57. https://​doi.​org/​10.​1056/​NEJMOA0904327/​SUPPL_​FILE/​NEJM_​WALLENTIN_​1045SA1.​PDF.CrossRefPubMed

go back to reference Turgeon RD, Koshman SL, Youngson E, Har B, Wilton SB, James MT, Graham MM. Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA Intern Med. 2020;180:420–8. https://doi.org/10.1001/JAMAINTERNMED.2019.6447.CrossRefPubMedPubMedCentral Turgeon RD, Koshman SL, Youngson E, Har B, Wilton SB, James MT, Graham MM. Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA Intern Med. 2020;180:420–8. https://​doi.​org/​10.​1001/​JAMAINTERNMED.​2019.​6447.CrossRefPubMedPubMedCentral

go back to reference Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Zamorano JL, Levine GN, Badimon L, Vranckx P, Agewall S, Andreotti F, Antman E, Barbato E, Bassand JP, Bugiardini R, Cikirikcioglu M, Cuisset T, De Bonis M, Delgado V, Fitzsimons D, Galiè N, Gilard M, Hamm CW, Ibanez B, James S, Knuuti J, Landmesser U, Leclercq C, Lettino M, Lip G, Piepoli MF, Pierard L, Schwerzmann M, Sechtem U, Simpson IA, Uva MS, Stabile E, Storey RF, Tendera M, Van De Werf F, Verheugt F, Aboyans V, Windecker S, Coca A, Coman IM, Dean V, Delgado V, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Lancellotti P, McDonagh T, Ponikowski P, DiJ R, Shlyakhto E, Roithinger FX, Aliyev F, Stelmashok V, Desmet W, Postadzhiyan A, Georghiou GP, Motovska Z, Grove EL, Marandi T, Kiviniemi T, Kedev S, Massberg S, Di A, Kiss RG, Gudmundsdottir IJ, McFadden EP, Lev E, De Luca L, Sugraliyev A, Haliti E, Mirrakhimov E, Latkovskis G, Petrauskiene B, Huijnen S, Magri CJ, Cherradi R, Ten Berg JM, Eritsland J, Budaj A, Aguiar CT, Duplyakov D, Zavatta M, Antonijevic NM, Fras Z, Montoliu AT, Varenhorst C, Di T, Addad F, Aydogdu S, Parkhomenko A, Kinnaird T. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213–60. https://doi.org/10.1093/EURHEARTJ/EHX419.CrossRefPubMed Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Zamorano JL, Levine GN, Badimon L, Vranckx P, Agewall S, Andreotti F, Antman E, Barbato E, Bassand JP, Bugiardini R, Cikirikcioglu M, Cuisset T, De Bonis M, Delgado V, Fitzsimons D, Galiè N, Gilard M, Hamm CW, Ibanez B, James S, Knuuti J, Landmesser U, Leclercq C, Lettino M, Lip G, Piepoli MF, Pierard L, Schwerzmann M, Sechtem U, Simpson IA, Uva MS, Stabile E, Storey RF, Tendera M, Van De Werf F, Verheugt F, Aboyans V, Windecker S, Coca A, Coman IM, Dean V, Delgado V, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Lancellotti P, McDonagh T, Ponikowski P, DiJ R, Shlyakhto E, Roithinger FX, Aliyev F, Stelmashok V, Desmet W, Postadzhiyan A, Georghiou GP, Motovska Z, Grove EL, Marandi T, Kiviniemi T, Kedev S, Massberg S, Di A, Kiss RG, Gudmundsdottir IJ, McFadden EP, Lev E, De Luca L, Sugraliyev A, Haliti E, Mirrakhimov E, Latkovskis G, Petrauskiene B, Huijnen S, Magri CJ, Cherradi R, Ten Berg JM, Eritsland J, Budaj A, Aguiar CT, Duplyakov D, Zavatta M, Antonijevic NM, Fras Z, Montoliu AT, Varenhorst C, Di T, Addad F, Aydogdu S, Parkhomenko A, Kinnaird T. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213–60. https://​doi.​org/​10.​1093/​EURHEARTJ/​EHX419.CrossRefPubMed

go back to reference Zocca P, Kok MM, van der Heijden LC, van Houwelingen KG, Hartmann M, de Man FHAF, Stoel MG, Louwerenburg JW, Knottnerus IL, Linssen GCM, Doggen CJM, von Birgelen C. High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT. Int J Cardiol. 2018;268:11–7. https://doi.org/10.1016/j.ijcard.2018.03.116.CrossRefPubMed Zocca P, Kok MM, van der Heijden LC, van Houwelingen KG, Hartmann M, de Man FHAF, Stoel MG, Louwerenburg JW, Knottnerus IL, Linssen GCM, Doggen CJM, von Birgelen C. High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT. Int J Cardiol. 2018;268:11–7. https://​doi.​org/​10.​1016/​j.​ijcard.​2018.​03.​116.CrossRefPubMed

go back to reference Wu H, Xiang X, Li D, Shen S, Li X. Efficacy and safety of ticagrelor compared to clopidogrel in patients undergoing percutaneous coronary intervention: a meta-analysis. Curr Pharm Des. 2020;26:5988–97. https://doi.org/10.2174/1381612826666200614184007.CrossRefPubMed Wu H, Xiang X, Li D, Shen S, Li X. Efficacy and safety of ticagrelor compared to clopidogrel in patients undergoing percutaneous coronary intervention: a meta-analysis. Curr Pharm Des. 2020;26:5988–97. https://​doi.​org/​10.​2174/​1381612826666200​614184007.CrossRefPubMed

go back to reference Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https://doi.org/10.1136/BMJ.N71.CrossRefPubMedPubMedCentral Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https://​doi.​org/​10.​1136/​BMJ.​N71.CrossRefPubMedPubMedCentral

go back to reference Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang TY, Gibler WB, Ohman EM, Roe MT, Pollack CV, Peterson ED, Alexander KP. Baseline risk of major bleeding in non-sT-segment- elevation myocardial infarction the CRUSADE (can rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score. Circulation. 2009;119:1873–82. https://doi.org/10.1161/CIRCULATIONAHA.108.828541.CrossRefPubMedPubMedCentral Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang TY, Gibler WB, Ohman EM, Roe MT, Pollack CV, Peterson ED, Alexander KP. Baseline risk of major bleeding in non-sT-segment- elevation myocardial infarction the CRUSADE (can rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score. Circulation. 2009;119:1873–82. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​108.​828541.CrossRefPubMedPubMedCentral

go back to reference Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC. Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation. 2019;140:240–61. https://doi.org/10.1161/CIRCULATIONAHA.119.040167.CrossRefPubMedPubMedCentral Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC. Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation. 2019;140:240–61. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​119.​040167.CrossRefPubMedPubMedCentral

go back to reference Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389:1025–34. https://doi.org/10.1016/S0140-6736(17)30397-5.CrossRefPubMed Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389:1025–34. https://​doi.​org/​10.​1016/​S0140-6736(17)30397-5.CrossRefPubMed

go back to reference D’Ascenzo F, De Filippo O, Gallone G, Mittone G, Deriu MA, Iannaccone M, Ariza-Solé A, Liebetrau C, Manzano-Fernández S, Quadri G, Kinnaird T, Campo G, Simao Henriques JP, Hughes JM, Dominguez-Rodriguez A, Aldinucci M, Morbiducci U, Patti G, Raposeiras-Roubin S, Abu-Assi E, De Ferrari GM, Piroli F, Saglietto A, Conrotto F, Omedé P, Montefusco A, Pennone M, Bruno F, Bocchino PP, Boccuzzi G, Cerrato E, Varbella F, Sperti M, Wilton SB, Velicki L, Xanthopoulou I, Cequier A, Iniguez-Romo A, Munoz Pousa I, Cespon Fernandez M, Caneiro Queija B, Cobas-Paz R, Lopez-Cuenca A, Garay A, Blanco PF, Rognoni A, Biondi Zoccai G, Biscaglia S, Nunez-Gil I, Fujii T, Durante A, Song X, Kawaji T, Alexopoulos D, Huczek Z, Gonzalez Juanatey JR, Nie SP, Kawashiri M, Colonnelli I, Cantalupo B, Esposito R, Leonardi S, Grosso Marra W, Chieffo A, Michelucci U, Piga D, Malavolta M, Gili S, Mennuni M, Montalto C, Oltrona Visconti L, Arfat Y. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet. 2021;397:199–207. https://doi.org/10.1016/S0140-6736(20)32519-8.CrossRefPubMed D’Ascenzo F, De Filippo O, Gallone G, Mittone G, Deriu MA, Iannaccone M, Ariza-Solé A, Liebetrau C, Manzano-Fernández S, Quadri G, Kinnaird T, Campo G, Simao Henriques JP, Hughes JM, Dominguez-Rodriguez A, Aldinucci M, Morbiducci U, Patti G, Raposeiras-Roubin S, Abu-Assi E, De Ferrari GM, Piroli F, Saglietto A, Conrotto F, Omedé P, Montefusco A, Pennone M, Bruno F, Bocchino PP, Boccuzzi G, Cerrato E, Varbella F, Sperti M, Wilton SB, Velicki L, Xanthopoulou I, Cequier A, Iniguez-Romo A, Munoz Pousa I, Cespon Fernandez M, Caneiro Queija B, Cobas-Paz R, Lopez-Cuenca A, Garay A, Blanco PF, Rognoni A, Biondi Zoccai G, Biscaglia S, Nunez-Gil I, Fujii T, Durante A, Song X, Kawaji T, Alexopoulos D, Huczek Z, Gonzalez Juanatey JR, Nie SP, Kawashiri M, Colonnelli I, Cantalupo B, Esposito R, Leonardi S, Grosso Marra W, Chieffo A, Michelucci U, Piga D, Malavolta M, Gili S, Mennuni M, Montalto C, Oltrona Visconti L, Arfat Y. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet. 2021;397:199–207. https://​doi.​org/​10.​1016/​S0140-6736(20)32519-8.CrossRefPubMed

go back to reference Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll H-P, Morice M-C. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med. 2015;373:2038–47. https://doi.org/10.1056/NEJMOA1503943/SUPPL_FILE/NEJMOA1503943_DISCLOSURES.PDF.CrossRefPubMed Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll H-P, Morice M-C. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med. 2015;373:2038–47. https://​doi.​org/​10.​1056/​NEJMOA1503943/​SUPPL_​FILE/​NEJMOA1503943_​DISCLOSURES.​PDF.CrossRefPubMed

go back to reference Gragnano F, Moscarella E, Calabrò P, Cesaro A, Pafundi PC, Ielasi A, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Gaudio C, Sasso FC, Pengo V, Gresele P, Marcucci R, Fimiani F, Vitale RA, Schiavo A, Conte M, Di Maio D, Pastori D, Menichelli D, Grossi G, Di Serafino L, Taglialatela V, Galiero R, Acierno C, del Pinto M, Gugliemini G. Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry. Intern Emerg Med. 2021;16:379–87. https://doi.org/10.1007/s11739-020-02404-1.CrossRefPubMed Gragnano F, Moscarella E, Calabrò P, Cesaro A, Pafundi PC, Ielasi A, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Gaudio C, Sasso FC, Pengo V, Gresele P, Marcucci R, Fimiani F, Vitale RA, Schiavo A, Conte M, Di Maio D, Pastori D, Menichelli D, Grossi G, Di Serafino L, Taglialatela V, Galiero R, Acierno C, del Pinto M, Gugliemini G. Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry. Intern Emerg Med. 2021;16:379–87. https://​doi.​org/​10.​1007/​s11739-020-02404-1.CrossRefPubMed

go back to reference Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials. Circulation. 2011;123:2736–47. https://doi.org/10.1161/CIRCULATIONAHA.110.009449.CrossRefPubMed Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials. Circulation. 2011;123:2736–47. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​110.​009449.CrossRefPubMed

go back to reference Wang HY, Li Y, Xu XM, Li J, Han YL. Impact of baseline bleeding risk on efficacy and safety of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. Chin Med J (Engl). 2018;131:2017–24. https://doi.org/10.4103/0366-6999.239306.CrossRefPubMed Wang HY, Li Y, Xu XM, Li J, Han YL. Impact of baseline bleeding risk on efficacy and safety of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. Chin Med J (Engl). 2018;131:2017–24. https://​doi.​org/​10.​4103/​0366-6999.​239306.CrossRefPubMed

go back to reference Patti G, D’Ascenzo F, De Filippo O, Bruno F, Leonardi S, Chieffo A, Iannaccone M, Liebetrau C, Manzano-Fernández S, Gallone G, Omedè P, Cerrato E, Kinnaird T, Conrotto F, Piroli F, Henriques JPS, Wan W, Elia E, Dominguez-Rodriguez A, Raposeiras-Roubin S, Abu-Assi E, De Ferrari GM. Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study. Eur Heart J Qual Care Clin Outcomes. 2022;8:881–91. https://doi.org/10.1093/ehjqcco/qcac002.CrossRefPubMed Patti G, D’Ascenzo F, De Filippo O, Bruno F, Leonardi S, Chieffo A, Iannaccone M, Liebetrau C, Manzano-Fernández S, Gallone G, Omedè P, Cerrato E, Kinnaird T, Conrotto F, Piroli F, Henriques JPS, Wan W, Elia E, Dominguez-Rodriguez A, Raposeiras-Roubin S, Abu-Assi E, De Ferrari GM. Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study. Eur Heart J Qual Care Clin Outcomes. 2022;8:881–91. https://​doi.​org/​10.​1093/​ehjqcco/​qcac002.CrossRefPubMed

go back to reference Lee WC, Fang CY, Tsai YH, Hsieh YY, Chen TY, Fang YN, Chen HC, Wu PJ, Fang HY. Comparison of clinical outcomes between ticagrelor and clopidogrel in East-Asian patients with acute coronary syndrome: large cohort study. Am J Cardiovasc Drugs. 2023;23:573–81. https://doi.org/10.1007/s40256-023-00603-7.CrossRefPubMed Lee WC, Fang CY, Tsai YH, Hsieh YY, Chen TY, Fang YN, Chen HC, Wu PJ, Fang HY. Comparison of clinical outcomes between ticagrelor and clopidogrel in East-Asian patients with acute coronary syndrome: large cohort study. Am J Cardiovasc Drugs. 2023;23:573–81. https://​doi.​org/​10.​1007/​s40256-023-00603-7.CrossRefPubMed

go back to reference Lee J, Kim MJ, Kim M, Park J, Kim H, Cho S, Choi Y, Lee J, Kim JH, Cha SJ, Kim TO, Kang DY, Lee PH, Ahn JM, Park SJ, Park DW. Validation of academic research consortium for high bleeding risk definition in East-Asian patients. JACC Asia. 2023;3:390–9. https://doi.org/10.1016/j.jacasi.2022.11.012.CrossRefPubMedPubMedCentral Lee J, Kim MJ, Kim M, Park J, Kim H, Cho S, Choi Y, Lee J, Kim JH, Cha SJ, Kim TO, Kang DY, Lee PH, Ahn JM, Park SJ, Park DW. Validation of academic research consortium for high bleeding risk definition in East-Asian patients. JACC Asia. 2023;3:390–9. https://​doi.​org/​10.​1016/​j.​jacasi.​2022.​11.​012.CrossRefPubMedPubMedCentral

go back to reference Bovill EG, Terrin ML, Stump DC, Berke AD, Frederick M, Collen D, Feit F, Gore JM, Hillis LD, Lambrew CT, Leiboff R, Mann KG, Markis JE, Pratt CM, Sharkey SW, Sopko G, Tracy RP, Chesebro JH. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Ann Intern Med. 1991;115:256–65. https://doi.org/10.7326/0003-4819-115-4-256.CrossRefPubMed Bovill EG, Terrin ML, Stump DC, Berke AD, Frederick M, Collen D, Feit F, Gore JM, Hillis LD, Lambrew CT, Leiboff R, Mann KG, Markis JE, Pratt CM, Sharkey SW, Sopko G, Tracy RP, Chesebro JH. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Ann Intern Med. 1991;115:256–65. https://​doi.​org/​10.​7326/​0003-4819-115-4-256.CrossRefPubMed

go back to reference Xiao P, Xie F, Lan Y. Efficacy and safety of ticagrelor versus clopidogrel with different dosages in acute coronary syndrome patients with high GRACE and CRUSADE scores. Indian Heart J. 2021;73:273–80. https://doi.org/10.1016/j.ihj.2021.02.002.CrossRefPubMedPubMedCentral Xiao P, Xie F, Lan Y. Efficacy and safety of ticagrelor versus clopidogrel with different dosages in acute coronary syndrome patients with high GRACE and CRUSADE scores. Indian Heart J. 2021;73:273–80. https://​doi.​org/​10.​1016/​j.​ihj.​2021.​02.​002.CrossRefPubMedPubMedCentral

go back to reference Tjerkaski J, Jernberg T, Alfredsson J, Erlinge D, James S, Lindahl B, Mohammad MA, Omerovic E, Venetsanos D, Szummer K. Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk. Eur Heart J Cardiovasc Pharmacother. 2023. https://doi.org/10.1093/ehjcvp/pvad041.CrossRefPubMedPubMedCentral Tjerkaski J, Jernberg T, Alfredsson J, Erlinge D, James S, Lindahl B, Mohammad MA, Omerovic E, Venetsanos D, Szummer K. Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk. Eur Heart J Cardiovasc Pharmacother. 2023. https://​doi.​org/​10.​1093/​ehjcvp/​pvad041.CrossRefPubMedPubMedCentral

go back to reference Zocca P, van der Heijden L, Kok M, Löwik M, Hartmann M, Stoel M, Louwerenburg J, de Man F, Linssen G, Knottnerus I, Doggen C, van Houwelingen K, von Birgelen C. Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT. EuroIntervention. 2017;13:1168–76. https://doi.org/10.4244/EIJ-D-17-00634.CrossRefPubMed Zocca P, van der Heijden L, Kok M, Löwik M, Hartmann M, Stoel M, Louwerenburg J, de Man F, Linssen G, Knottnerus I, Doggen C, van Houwelingen K, von Birgelen C. Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT. EuroIntervention. 2017;13:1168–76. https://​doi.​org/​10.​4244/​EIJ-D-17-00634.CrossRefPubMed

go back to reference Fordyce CB, Giugliano RP, Cannon CP, Roe MT, Sharma A, Page C, White JA, Lokhnygina Y, Braunwald E, Blazing MA. Cardiovascular events and long-term risk of sudden death among stabilized patients after acute coronary syndrome: insights from IMPROVE-IT. J Am Heart Assoc. 2022. https://doi.org/10.1161/JAHA.121.022733.CrossRefPubMedPubMedCentral Fordyce CB, Giugliano RP, Cannon CP, Roe MT, Sharma A, Page C, White JA, Lokhnygina Y, Braunwald E, Blazing MA. Cardiovascular events and long-term risk of sudden death among stabilized patients after acute coronary syndrome: insights from IMPROVE-IT. J Am Heart Assoc. 2022. https://​doi.​org/​10.​1161/​JAHA.​121.​022733.CrossRefPubMedPubMedCentral

go back to reference Fujisaki T, Kuno T, Ando T, Briasoulis A, Takagi H, Bangalore S. Potent P2Y12 inhibitors versus Clopidogrel in elderly patients with acute coronary syndrome: systematic review and meta-analysis. Am Heart J. 2021;237:34–44. https://doi.org/10.1016/j.ahj.2021.03.009.CrossRefPubMed Fujisaki T, Kuno T, Ando T, Briasoulis A, Takagi H, Bangalore S. Potent P2Y12 inhibitors versus Clopidogrel in elderly patients with acute coronary syndrome: systematic review and meta-analysis. Am Heart J. 2021;237:34–44. https://​doi.​org/​10.​1016/​j.​ahj.​2021.​03.​009.CrossRefPubMed

go back to reference Xie C, Lin J, Qin Q, Zhu J. Efficacy and safety of ticagrelor in east Asian patients with acute coronary syndrome: a meta-analysis of randomized controlled trials. Anatol J Cardiol. 2022;26:434–41. https://doi.org/10.5152/AnatolJCardiol.2022.1144.CrossRefPubMedPubMedCentral Xie C, Lin J, Qin Q, Zhu J. Efficacy and safety of ticagrelor in east Asian patients with acute coronary syndrome: a meta-analysis of randomized controlled trials. Anatol J Cardiol. 2022;26:434–41. https://​doi.​org/​10.​5152/​AnatolJCardiol.​2022.​1144.CrossRefPubMedPubMedCentral

go back to reference Bergh N, Myredal A, Nivedahl P, Petzold M, Zarin S, Wartenberg C, Wallerstedt SM. Efficacy and safety of clopidogrel versus ticagrelor as part of dual antiplatelet therapy in acute coronary syndrome—a systematic review and meta-analysis. J Cardiovasc Pharmacol. 2022;79:620–31. https://doi.org/10.1097/FJC.0000000000001233.CrossRefPubMed Bergh N, Myredal A, Nivedahl P, Petzold M, Zarin S, Wartenberg C, Wallerstedt SM. Efficacy and safety of clopidogrel versus ticagrelor as part of dual antiplatelet therapy in acute coronary syndrome—a systematic review and meta-analysis. J Cardiovasc Pharmacol. 2022;79:620–31. https://​doi.​org/​10.​1097/​FJC.​0000000000001233​.CrossRefPubMed

go back to reference Bonello L, Laine M, Lemesle G, Puymirat E, Dabry T, Thuny F, Paganelli F, Aradi D, Frere C, Burtey S, Sibbing D, Mancini J. Meta-analysis of potent P2Y12-ADP receptor antagonist therapy compared to clopidogrel therapy in acute coronary syndrome patients with chronic kidney disease. Thromb Haemost. 2018;118:1839–46. https://doi.org/10.1055/s-0038-1669426.CrossRefPubMed Bonello L, Laine M, Lemesle G, Puymirat E, Dabry T, Thuny F, Paganelli F, Aradi D, Frere C, Burtey S, Sibbing D, Mancini J. Meta-analysis of potent P2Y12-ADP receptor antagonist therapy compared to clopidogrel therapy in acute coronary syndrome patients with chronic kidney disease. Thromb Haemost. 2018;118:1839–46. https://​doi.​org/​10.​1055/​s-0038-1669426.CrossRefPubMed

go back to reference Gao S, Xu H, Huang S, Yuan J, Yu M. Real-world use of clopidogrel and ticagrelor in patients with myocardial infarction with nonobstructive coronary arteries: patient characteristics and long-term outcomes. Front Cardiovasc Med. 2021. https://doi.org/10.3389/fcvm.2021.807494.CrossRefPubMedPubMedCentral Gao S, Xu H, Huang S, Yuan J, Yu M. Real-world use of clopidogrel and ticagrelor in patients with myocardial infarction with nonobstructive coronary arteries: patient characteristics and long-term outcomes. Front Cardiovasc Med. 2021. https://​doi.​org/​10.​3389/​fcvm.​2021.​807494.CrossRefPubMedPubMedCentral

go back to reference Kwon O, Park D-W. Antithrombotic therapy after acute coronary syndromes or percutaneous coronary interventions in East Asian populations. JACC Asia. 2022;2:1–18. https://doi.org/10.1016/j.jacasi.2021.12.005.CrossRefPubMedPubMedCentral Kwon O, Park D-W. Antithrombotic therapy after acute coronary syndromes or percutaneous coronary interventions in East Asian populations. JACC Asia. 2022;2:1–18. https://​doi.​org/​10.​1016/​j.​jacasi.​2021.​12.​005.CrossRefPubMedPubMedCentral

go back to reference Wu B, Lin H, Tobe RG, Zhang L, He B. Ticagrelor versus clopidogrel in East-Asian patients with acute coronary syndromes: a meta-analysis of randomized trials. J Comp Eff Res. 2018;7:281–91. https://doi.org/10.2217/cer-2017-0074.CrossRefPubMed Wu B, Lin H, Tobe RG, Zhang L, He B. Ticagrelor versus clopidogrel in East-Asian patients with acute coronary syndromes: a meta-analysis of randomized trials. J Comp Eff Res. 2018;7:281–91. https://​doi.​org/​10.​2217/​cer-2017-0074.CrossRefPubMed

go back to reference Kheiri B, Osman M, Abdalla A, Haykal T, Barbarawi M, Zayed Y, Hicks M, Ahmed S, Bachuwa G, Hassan M, Bhatt DL. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials. J Thromb Thrombolysis. 2018;46:299–303. https://doi.org/10.1007/s11239-018-1706-2.CrossRefPubMed Kheiri B, Osman M, Abdalla A, Haykal T, Barbarawi M, Zayed Y, Hicks M, Ahmed S, Bachuwa G, Hassan M, Bhatt DL. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials. J Thromb Thrombolysis. 2018;46:299–303. https://​doi.​org/​10.​1007/​s11239-018-1706-2.CrossRefPubMed

go back to reference Yang J, Zeng P, Cai W. Comparison of treatment outcomes of ticagrelor and clopidogrel among patients undergoing percutaneous coronary intervention: a meta-analysis. Curr Med Sci. 2017;37:675–80. https://doi.org/10.1007/s11596-017-1788-7.CrossRef Yang J, Zeng P, Cai W. Comparison of treatment outcomes of ticagrelor and clopidogrel among patients undergoing percutaneous coronary intervention: a meta-analysis. Curr Med Sci. 2017;37:675–80. https://​doi.​org/​10.​1007/​s11596-017-1788-7.CrossRef

go back to reference Patlolla SH, Kandlakunta H, Kuchkuntla AR, West CP, Murad MH, Wang Z, Kochar A, Rab ST, Gersh BJ, Holmes DR, Zhao DX, Vallabhajosyula S. Newer P2Y12 inhibitors vs clopidogrel in acute myocardial infarction with cardiac arrest or cardiogenic shock: a systematic review and meta-analysis. Mayo Clin Proc. 2022;97:1074–85. https://doi.org/10.1016/j.mayocp.2022.02.016.CrossRefPubMed Patlolla SH, Kandlakunta H, Kuchkuntla AR, West CP, Murad MH, Wang Z, Kochar A, Rab ST, Gersh BJ, Holmes DR, Zhao DX, Vallabhajosyula S. Newer P2Y12 inhibitors vs clopidogrel in acute myocardial infarction with cardiac arrest or cardiogenic shock: a systematic review and meta-analysis. Mayo Clin Proc. 2022;97:1074–85. https://​doi.​org/​10.​1016/​j.​mayocp.​2022.​02.​016.CrossRefPubMed

go back to reference Goto S, Huang C-H, Park S-J, Emanuelsson H, Kimura T. Ticagrelor vs. clopidogrel in japanese, korean and taiwanese patients with acute coronary syndrome—randomized, double-blind, phase III PHILO study. Circ J. 2015;79:2452–60. https://doi.org/10.1253/circj.CJ-15-0112.CrossRefPubMed Goto S, Huang C-H, Park S-J, Emanuelsson H, Kimura T. Ticagrelor vs. clopidogrel in japanese, korean and taiwanese patients with acute coronary syndrome—randomized, double-blind, phase III PHILO study. Circ J. 2015;79:2452–60. https://​doi.​org/​10.​1253/​circj.​CJ-15-0112.CrossRefPubMed

go back to reference Levine GN, Jeong Y-H, Goto S, Anderson JL, Huo Y, Mega JL, Taubert K, Smith SC. World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014;11:597–606. https://doi.org/10.1038/nrcardio.2014.104.CrossRefPubMed Levine GN, Jeong Y-H, Goto S, Anderson JL, Huo Y, Mega JL, Taubert K, Smith SC. World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014;11:597–606. https://​doi.​org/​10.​1038/​nrcardio.​2014.​104.CrossRefPubMed

go back to reference Fan Z-G, Zhang W-L, Xu B, Ji J, Tian N-L, He S-H. Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis. Drug Des Dev Ther. 2019;13:719–30. https://doi.org/10.2147/DDDT.S196535.CrossRef Fan Z-G, Zhang W-L, Xu B, Ji J, Tian N-L, He S-H. Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis. Drug Des Dev Ther. 2019;13:719–30. https://​doi.​org/​10.​2147/​DDDT.​S196535.CrossRef

go back to reference Wang Z, Zhou D-Y, Su Y, Si L-Y, Xu Q. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis. BMC Cardiovasc Disord. 2020;20:130. https://doi.org/10.1186/s12872-020-01403-6.CrossRefPubMedPubMedCentral Wang Z, Zhou D-Y, Su Y, Si L-Y, Xu Q. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis. BMC Cardiovasc Disord. 2020;20:130. https://​doi.​org/​10.​1186/​s12872-020-01403-6.CrossRefPubMedPubMedCentral

go back to reference Hong J, Turgeon RD, Pearson GJ. Switching to clopidogrel in patients with acute coronary syndrome managed with percutaneous coronary intervention initially treated with prasugrel or ticagrelor: systematic review and meta-analysis. Ann Pharmacother. 2019;53:997–1004. https://doi.org/10.1177/1060028019845334.CrossRefPubMed Hong J, Turgeon RD, Pearson GJ. Switching to clopidogrel in patients with acute coronary syndrome managed with percutaneous coronary intervention initially treated with prasugrel or ticagrelor: systematic review and meta-analysis. Ann Pharmacother. 2019;53:997–1004. https://​doi.​org/​10.​1177/​1060028019845334​.CrossRefPubMed

go back to reference Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan G-A, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Jüni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, Halvorsen S, James S, Abdelhamid M, Aboyans V, Marsan NA, Antoniou S, Asteggiano R, Bäck M, Capodanno D, Casado-Arroyo R, Cassese S, Čelutkienė J, Cikes M, Collet J-P, Ducrocq G, Falk V, Fauchier L, Geisler T, Gorog DA, Holmvang L, Jaarsma T, Jones HW, Køber L, Koskinas KC, Kotecha D, Krychtiuk KA, Landmesser U, Lazaros G, Lewis BS, Lindahl B, Linhart A, Løchen M-L, Mamas MA, McEvoy JW, Mihaylova B, Mindham R, Mueller C, Neubeck L, Niebauer J, Nielsen JC, Niessner A, Paradies V, Pasquet AA, Petersen SE, Prescott E, Rakisheva A, Rocca B, Rosano GMC, Sade LE, Schiele F, Siller-Matula JM, Sticherling C, Storey RF, Thielmann M, Vrints C, Windecker S, Wiseth R, Witkowski A, El Amine BM, Hayrapetyan H, Metzler B, Lancellotti P, Bajrić M, Karamfiloff K, Mitsis A, Ostadal P, Sørensen R, Elwasify T, Marandi T, Ryödi E, Collet J-P, Chukhrukidze A, Mehilli J, Davlouros P, Becker D, Guðmundsdóttir IJ, Crowley J, Abramowitz Y, Indolfi C, Sakhov O, Elezi S, Beishenkulov M, Erglis A, Moussallem N, Benlamin H, Dobilienė O, Degrell P, Balbi MM, Grosu A, Lakhal Z, ten Berg J, Pejkov H, Angel K, Witkowski A, De Sousa AM, Chioncel O, Bertelli L, Stojkovic S, Studenčan M, Radšel P, Ferreiro JL, Ravn-Fischer A, Räber L, Marjeh MYB, Hassine M, Yildirir A, Parkhomenko A, Banning AP, Prescott E, James S, Arbelo E, Baigent C, Borger MA, Buccheri S, Ibanez B, Køber L, Koskinas KC, McEvoy JW, Mihaylova B, Mindham R, Neubeck L, Nielsen JC, Pasquet AA, Rakisheva A, Rocca B, Rossello X, Vaartjes I, Vrints C, Witkowski A, Zeppenfeld K. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720–826. https://doi.org/10.1093/eurheartj/ehad191.CrossRefPubMed Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan G-A, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Jüni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, Halvorsen S, James S, Abdelhamid M, Aboyans V, Marsan NA, Antoniou S, Asteggiano R, Bäck M, Capodanno D, Casado-Arroyo R, Cassese S, Čelutkienė J, Cikes M, Collet J-P, Ducrocq G, Falk V, Fauchier L, Geisler T, Gorog DA, Holmvang L, Jaarsma T, Jones HW, Køber L, Koskinas KC, Kotecha D, Krychtiuk KA, Landmesser U, Lazaros G, Lewis BS, Lindahl B, Linhart A, Løchen M-L, Mamas MA, McEvoy JW, Mihaylova B, Mindham R, Mueller C, Neubeck L, Niebauer J, Nielsen JC, Niessner A, Paradies V, Pasquet AA, Petersen SE, Prescott E, Rakisheva A, Rocca B, Rosano GMC, Sade LE, Schiele F, Siller-Matula JM, Sticherling C, Storey RF, Thielmann M, Vrints C, Windecker S, Wiseth R, Witkowski A, El Amine BM, Hayrapetyan H, Metzler B, Lancellotti P, Bajrić M, Karamfiloff K, Mitsis A, Ostadal P, Sørensen R, Elwasify T, Marandi T, Ryödi E, Collet J-P, Chukhrukidze A, Mehilli J, Davlouros P, Becker D, Guðmundsdóttir IJ, Crowley J, Abramowitz Y, Indolfi C, Sakhov O, Elezi S, Beishenkulov M, Erglis A, Moussallem N, Benlamin H, Dobilienė O, Degrell P, Balbi MM, Grosu A, Lakhal Z, ten Berg J, Pejkov H, Angel K, Witkowski A, De Sousa AM, Chioncel O, Bertelli L, Stojkovic S, Studenčan M, Radšel P, Ferreiro JL, Ravn-Fischer A, Räber L, Marjeh MYB, Hassine M, Yildirir A, Parkhomenko A, Banning AP, Prescott E, James S, Arbelo E, Baigent C, Borger MA, Buccheri S, Ibanez B, Køber L, Koskinas KC, McEvoy JW, Mihaylova B, Mindham R, Neubeck L, Nielsen JC, Pasquet AA, Rakisheva A, Rocca B, Rossello X, Vaartjes I, Vrints C, Witkowski A, Zeppenfeld K. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720–826. https://​doi.​org/​10.​1093/​eurheartj/​ehad191.CrossRefPubMed

go back to reference Wang Y, Yang N, Suo M, Liu X, Wang Z, Zhang X, Liu J, Zhao D, Wu X. In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: findings from the CCC-ACS project. Thromb Res. 2022;216:43–51. https://doi.org/10.1016/j.thromres.2022.04.004.CrossRefPubMed Wang Y, Yang N, Suo M, Liu X, Wang Z, Zhang X, Liu J, Zhao D, Wu X. In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: findings from the CCC-ACS project. Thromb Res. 2022;216:43–51. https://​doi.​org/​10.​1016/​j.​thromres.​2022.​04.​004.CrossRefPubMed